Cargando…
Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
Orally administered antipsychotic drugs are the first-line treatment for psychotic disorders, such as schizophrenia and bipolar disorder. Nevertheless, adverse drug reactions jeopardize clinical outcomes, resulting in patient non-compliance. The design formulation strategies for enhancing brain drug...
Autores principales: | Ferreira, Maria Daniela, Duarte, Joana, Veiga, Francisco, Paiva-Santos, Ana Cláudia, Pires, Patrícia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959474/ https://www.ncbi.nlm.nih.gov/pubmed/36840000 http://dx.doi.org/10.3390/pharmaceutics15020678 |
Ejemplares similares
-
Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
por: Antunes, Jéssica L., et al.
Publicado: (2023) -
Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
por: Pires, Patrícia C., et al.
Publicado: (2023) -
Antipsychotics-Loaded Nanometric Emulsions for Brain Delivery
por: Pires, Patrícia C., et al.
Publicado: (2022) -
Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy
por: Pires, Patrícia C., et al.
Publicado: (2022) -
Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities
por: Grifoni, Lucia, et al.
Publicado: (2022)